Rite Aid Forecast Cut a `Tough Blow' Before Albertsons Vote
(Bloomberg) -- Rite Aid Corp.'s reduced full-year earnings projection leaves shareholders in a quandary just three days ahead of a vote on the company's merger with Albertsons Cos.
Commentary from the two biggest proxy advisers painted a gloomy picture for the deal vote scheduled Aug. 9, as holders typically stick with the adviser recommendations. Now, investors will have to weigh the worsening profitability outlook against the risks associated with the deal. Shares plunged as much as 12.5 percent on Monday, the most since late June.
The lower guidance is a “tough blow” to shareholders given its proximity to the merger vote, Evercore analyst Ross Muken wrote in a note. “We have continued to view the outcome as ‘lose, lose' and this update does nothing to change that view.”
Muken's sour view isn't in isolation. Susquehanna litigation analyst Joseph Stauff wrote earlier that the drug store's profit warning would do little to persuade shareholders against voting down the Albertsons deal.
“We think investors can easily “see though” the intent of this am's tactic, but do not believe it will ‘scare' enough votes into the ‘yes' category to matter,” Stauff wrote. Rite Aid's “lowered guidance” three days before vote is a very “unusual” move to get more votes, though the “aggressiveness” of the move suggests that Albertsons needs “considerably” more votes to get the deal completed, he added.
Rite Aid investors can't seem to catch a break. The stock has plummeted 77 percent in the past two years, as its takeover by Walgreens Boots Alliance Inc. fell apart amid antitrust scrutiny. Walgreens eventually agreed to buy 1,932 Rite Aid stores, leaving behind a far smaller company with a now more uncertain future.
ISS reiterated its recommendation against the deal with no changes to its advice in an updated note, writing that today's new information doesn't alter the basis for its original analysis. Albertsons, backed by private equity firm Cerberus Capital Management LP, didn't immediately return calls seeking comment. Rite Aid said there is no change to timing of holder meeting.
--With assistance from Scott Deveau.
To contact the reporters on this story: Tatiana Darie in New York at tdarie1@bloomberg.net;Joshua Fineman in New York at jfineman@bloomberg.net
To contact the editors responsible for this story: Catherine Larkin at clarkin4@bloomberg.net, Brad Olesen
©2018 Bloomberg L.P.
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.